NCT05415163

Brief Summary

Randomized clinical trial to evaluate the effect of vascular photobiomodulation on sleep quality, relaxation and stress when compared to placebo.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

June 8, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 10, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
Last Updated

October 5, 2022

Status Verified

October 1, 2022

Enrollment Period

5 months

First QC Date

June 8, 2022

Last Update Submit

October 4, 2022

Conditions

Keywords

stresssleep disorderphotobiomodulationlaser therapy

Outcome Measures

Primary Outcomes (1)

  • Quality of sleep

    Quality of sleep evaluated by Pittsburgh Sleep Quality Index

    five weeks

Study Arms (2)

vascular photobiomodulation

EXPERIMENTAL

Laser will be applied with the spot located in the radial artery of the participant's arm (right or left), and fixed to the wrist with a specific bracelet.

Procedure: vascular photobiomodulation

photbiomodulation-sham

SHAM COMPARATOR

The device will be placed with the spot located in the radial artery of the participant's arm (right or left), and fixed to the wrist with a specific bracelet no laser apllied.

Procedure: vascular photobiomodulation

Interventions

application of photobiomodulation with the device O Ecco ILIB (Eccofibras, São Paulo, Brazil) containing its red wavelength 660 nm ± 10 nm and power 100 mW, with an application time of 30 minutes. The device will be positioned with the spot located in the radial artery of the participant's arm (right or left), and fixed to the wrist with a specific bracelet.

photbiomodulation-shamvascular photobiomodulation

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • poor sleep quality.
  • Participants who for at least six months have had poor sleep quality (score \> 5 points), measured using the PSQI,

You may not qualify if:

  • use medications or perform treatments that may affect the sleep cycle
  • treatment for hypertension
  • asthma,
  • attention deficit disorder,
  • diabetes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lara Motta

São Roque, São Paulo, 18133-399, Brazil

RECRUITING

MeSH Terms

Conditions

Stress Disorders, TraumaticSleep Wake Disorders

Condition Hierarchy (Ancestors)

Trauma and Stressor Related DisordersMental DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The photobiomodulation application devices are identical in both groups and in the placebo group the device will not emit light, only the sound signal. Both participant and researcher will wear protective eyewear and will not know which equipment is the active or placebo. Only a researcher external to the procedure will know which equipment is in each group
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

June 8, 2022

First Posted

June 10, 2022

Study Start

June 1, 2022

Primary Completion

November 10, 2022

Study Completion

December 20, 2022

Last Updated

October 5, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations